Skip to search formSkip to main contentSkip to account menu

Foradil

National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

formoterolformoterol fumarateformoterol fumarate dihydrate
formoterol Inhalant Powder [Foradil]formoterol fumarate 0.012 MG Inhalant Powder [Foradil]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.
Background: Co-Suspension™ Delivery Technology offers a novel pharmaceutical platform for inhaled drug therapy. This randomized… 
2006
2006
In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler.
Formoterol, a long-acting beta (2)-agonist with a rapid onset of bronchodilation, is available in various delivery devices… 
2006
2006
Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD
Background: Chronic obstructive pulmonary disease (COPD) management guidelines recommend regular treatment with one or more long… 
2004
2004
Comparable Efficacy and Tolerability of Formoterol (Foradil®) Administered via a Novel Multi-Dose Dry Powder Inhaler (Certihaler™) or the Aerolizer® Dry Powder Inhaler in Patients with Persistent…
Background: For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular… 
Review
2004
Review
2004
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease
Evaluation of patients with chronic obstructive pulmonary disease (COPD) often includes the use of post‐bronchodilator… 
2004
2004
Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo…
BACKGROUND In response to the phasing out of chlorofluorocarbon (CFC) inhalers, a metered dose hydrofluoroalkane (HFA… 
2003
2003
Formoterol Delivered via the Dry Powder Aerolizer® Inhaler Versus Albuterol MDI and Placebo in Mild-to-Moderate Asthma: A Randomized, Double-Blind, Double-Dummy Trial
The objectives of this study were to compare the efficacy and tolerability of twice-daily formoterol dry powder 12 µg and 24 µg… 
2003
2003
Miflonide®/Foradil® via Aerolizer® im Vergleich zu anderen antiinflammatorischen und antiobstruktiven Therapieregimes
Die Standardtherapie des mittelgradigen und schweren Asthma bronchiale besteht aus einer kombinierten antiinflammatorischen… 
2001
2001
SIMILAR EFFICACY FOLLOWING FOUR WEEKS TREATMENT OF ASTHMATICS WITH FORMOTEROL 12 μG B.D. DELIVERED BY TWO DIFFERENT DRY POWDER INHALERS: DIFFERENCES IN INHALER HANDLING
This randomised, multicentre, parallel‐group study compared the clinical efficacy and ease of handling of two dry powder inhalers… 
1999
1999
Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
BACKGROUND In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)